An electrochemical biosensor test strip with four new features. The test strip includes an indentation for tactile feel as to the location of the strips sample application port. The sample application port leads to a capillary test chamber, which includes a test reagent. The wet reagent includes from about 0.2% by weight to about 2% by weight polyethylene oxide from about 100 kilodaltons to about 900 kilodaltons mean molecular weight, which makes the dried reagent more hydrophilic and sturdier to strip processing steps, such as mechanical punching, and to mechanical manipulation by the test strip user. The roof of the capillary test chamber includes a transparent or translucent window which operates as a “fill to here” line, thereby identifying when enough test sample (a liquid sample, such as blood) has been added to the test chamber to accurately perform a test. The test strip may further include a notch located at the sample application port. The notch reduces a phenomenon called “dose hesitation”.

Patent
   RE42560
Priority
Dec 05 1997
Filed
Oct 24 2003
Issued
Jul 19 2011
Expiry
Dec 05 2017

TERM.DISCL.
Assg.orig
Entity
unknown
1
91
EXPIRED
0. 33. An electrochemical test strip for conducting testing for the concentration of glucose in a blood sample, comprising:
a strip body including an edge surface extending about the perimeter of said strip body, said strip body defining a capillary channel and a vent in fluid communication with the capillary channel, said strip body comprising a sample application port open at a location along the edge surface, the capillary channel having opposed sides extending from the sample application port to at least the vent;
at least working and counter electrodes spaced from each other and positioned within the capillary channel at a location spaced from the edge surface;
a test reagent adjacent at least the working electrode; and
visualization means associated with the capillary channel and including a solid, transparent or translucent viewing material extending from at least adjacent the sample application port and overlying at least a portion of the capillary channel including said working electrode and at least a portion of said counter electrode,
said strip body having opaque portions which, in combination with said viewing material, define a window effective for providing visual confirmation that a sufficient area of the working and counter electrodes is covered with sample to have a minimum sample amount for said test strip.
0. 43. An electrochemical test strip for conducting testing for the concentration of glucose in a blood sample, comprising:
a strip body including an edge surface extending about the perimeter of said strip body, said strip body defining a capillary channel and a vent in fluid communication with the capillary channel, said strip body comprising a sample application port open at a location along the perimetric edge surface, the capillary channel extending from the sample application port to at least the vent, said strip body further defining a test area along the capillary channel between the sample application port and the vent; at least working and counter electrodes spaced from each other and positioned within the test area of the capillary channel at a location spaced from the perimetric edge surface;
a test reagent received within the test area of the capillary channel and adjacent at least the working electrode;
said strip body including a solid, transparent or translucent viewing material overlying at least a portion of the capillary channel, including from a portion thereof at or generally adjacent the sample application port continuously up to and including said working electrode and at least a portion of said counter electrode, the viewing material permitting visualization of the blood sample as it moves through the capillary channel to the test area;
said strip body further including opaque portions defining a fill area viewable through the viewing material, the fill area extending from adjacent the sample application port continuously up to the working electrode and at least a part of the counter electrode and limited to an area of the capillary channel needed to be filled to conduct an accurate test;
wherein observation through the viewing material of the blood sample within the capillary channel up to said electrodes comprises confirmation of sufficient blood sample being introduced into the capillary channel to conduct a test.
0. 1. A test strip, having an indentation along an edge for tactile identification of a sample application port, said test strip comprising:
a first insulating substrate having first and second surfaces, an indentation along an edge and a vent hole;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces, an indentation along an edge, and first and second openings, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the first opening exposing a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the second opening being located along said edge and exposing a different portion of the conductive tracks and the vent hole;
a test reagent overlaying at least a portion of the conductive tracks exposed by the second opening; and
a roof having first and second surfaces and an indentation along an edge, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so that the second surface of the roof and the surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate, wherein the second opening in the second insulating substrate and the indentations in the first insulating substrate, the second insulating substrate, and the roof are aligned to thereby provide for tactile identification of the sample application port.
0. 2. The test strip of claim 1, wherein the second surface of the roof includes a hydrophilic coating.
0. 3. The test strip of claim 1, wherein the test reagent includes
reaction components appropriate for performing a test and from about 1.75% by weight to about 17.5% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the reagent will redissolve or resuspend upon addition of an aqueous test sample to the reagent.
0. 4. The test strip of claim 1, wherein the test reagent includes reaction components appropriate for performing a test, and a dissolvable or suspendable film forming mixture including from about 0.2% by weight to about 2% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the test reagent may be applied to the test strip in a wet form, may be subsequently dried, and then redissolved or resuspended upon addition of an aqueous test sample to the dried reagent.
0. 5. The test strip of claim 4, wherein the second surface of the roof includes a hydrophilic coating.
0. 6. The test strip of claim 1, wherein the roof has a solid transparent or translucent window, which is dimensioned and positioned so that the window overlays the entire width of the electrically conductive track that is closest to the indentation of the first insulating substrate and at least about ten percent of the width of the other electrically conductive track.
0. 7. The test strip of claim 6, wherein the second surface of the roof includes a hydrophilic coating.
0. 8. The test strip of claim 6, wherein the test reagent includes
reaction components appropriate for performing a test and from about 1.75% by weight to about 17.5% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the reagent will redissolve or resuspend upon addition of an aqueous test sample to the reagent.
0. 9. The test strip of claim 6, wherein the test reagent includes reaction components appropriate for performing a test, and a dissolvable or suspendable film forming mixture including from about 0.2% by weight to about 2% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the test reagent may be applied to the test strip in a wet form, may be subsequently dried, and then redissolved or resuspended upon addition of an aqueous test sample to the dried reagent.
0. 10. The test strip of claim 9, wherein the second surface of the roof includes a hydrophilic coating.
0. 11. The test strip of claim 1, further comprising:
a first notch along the indentation in the first insulating substrate, and a notch along the indentation in the roof, both first and second notches being positioned so that they overlay one another.
0. 12. The test strip of claim 11, wherein the second surface of the roof includes a hydrophilic coating.
0. 13. The test strip of claim 11, wherein the test reagent includes
reaction components appropriate for performing a test and from about 1.75% by weight to about 17.5% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the reagent will redissolve or resuspend upon addition of an aqueous test sample to the reagent.
0. 14. The test strip of claim 11, wherein the test reagent includes reaction components appropriate for performing a test, and a dissolvable or suspendable film forming mixture including from about 0.2% by weight to about 2% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the test reagent may be applied to the test strip in a wet form, may be subsequently dried, and then redissolved or resuspended upon addition of an aqueous test sample to the dried reagent.
0. 15. The test strip of claim 14, wherein the second surface of the roof includes a hydrophilic coating.
0. 16. The test strip of claim 11 wherein the roof has a solid transparent or translucent window, which is dimensioned and positioned so that the window overlays the entire width of the electrically conductive track that is closest to the indentation of the first insulating substrate and at least about ten percent of the width of the other electrically conductive track.
0. 17. The test strip of claim 16, wherein the second surface of the roof includes a hydrophilic coating.
0. 18. The test strip of claim 16, wherein the test reagent includes reaction components appropriate for performing a test, and a dissolvable or suspendable film forming mixture including from about 0.2% by weight to about 2% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the test reagent may be applied to the test strip in a wet form, may be subsequently dried, and then redissolved or resuspended upon addition of an aqueous test sample to the dried reagent.
0. 19. The test strip of claim 18, wherein the second surface of the roof includes a hydrophilic coating.
0. 20. The test strip of claim 16, wherein the test reagent includes reaction components appropriate for the test, and a dissolvable or suspendable film forming mixture including from about 0.2% weight to about 2% by weight polyethylene oxide having a mean molecular weight of 300 kilodaltons.
0. 21. The test strip of claim 20, wherein the polyethylene oxide is about 0.71% by weight.
0. 22. The test strip of claim 16, wherein the test reagent includes
reaction components appropriate for performing a test and from about 1.75% by weight to about 17.5% by weight polyethylene oxide having a mean molecular weight from about 100 kilodaltons to about 900 kilodaltons,
wherein the reagent will redissolve or resuspend upon addition of an aqueous test sample to the reagent.
0. 23. The test strip of claim 22, wherein the mean molecular weight of the polyethylene oxide is 300 kilodaltons.
0. 24. The test strip of claim 23, wherein the amount of polyethylene oxide, in the reagent is about 6.2% by weight.
0. 25. A test strip comprising:
a first insulating substrate having first and second surfaces, a notch along an edge, and a vent hole;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces and first and second openings, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the first opening exposing a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the second opening being located along an edge of the second insulating substrate and exposing a different portion of the conductive tracks, the notch in the first insulating substrate, and the vent hole;
a test reagent overlaying at least a portion of the conductive tracks exposed by the second opening; and
a roof having first and second surfaces and a notch along an edge, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so that 1) the second surface of the roof and the first surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate, and 2) the notch in the roof overlays the notch in the first insulating substrate;
whereby the notch in the roof and the notch in the first insulating substrate will cause a liquid aqueous sample, when touched to the sample application port, to flow into the capillary chamber without significant hesitation.
0. 26. A test strip, comprising:
a first insulating substrate having first and second surfaces and a vent hole;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces and first and second openings, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the first opening exposing a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the second opening being located along an edge of the second insulating substrate and exposing a different portion of the conductive tracks and the vent hole;
a test reagent overlaying at least a portion of the conductive tracks exposed by the second opening; and
a roof having first and second surfaces and a solid transparent or translucent window, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so that it overlays the second opening of the second insulating substrate and so that the second surface of the roof and the first surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate, and the transparent or translucent window being dimensioned and positioned so that the window extends from the sample application port, and overlays the entire width of one of the electrically conductive tracks and at least about ten percent of the width of the other electrically conductive track.
0. 27. A test strip, having an indentation along an edge for tactile identification of a sample application port, said test strip comprising:
a first insulating substrate having first and second surfaces and an indentation along an edge;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces, an indentation along an edge and an opening, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the second insulating substrate configured to expose a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the opening being located along said edge and exposing a different portion of the conductive tracks;
a test reagent overlaying at least a portion of the conductive tracks exposed by the opening;
a roof having first and second surfaces and an indentation along an edge, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so as to overlay the opening and so that the second surface of the roof and the first surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate; and
a vent hole communicating with the capillary fill chamber;
wherein the opening in the second insulating substrate and the indentations in the first insulating substrate, the second insulating substrate, and the roof are aligned to thereby provide for tactile identification of the sample application port.
0. 28. The test strip of claim 27, wherein the roof has a solid transparent or translucent window, which is dimensioned and positioned so that the window overlays the entire width of the electrically conductive track that is closest to the indentation of the first insulating substrate and at least about ten percent of the width of the other electrically conductive track.
0. 29. The test strip of claim 27 further comprising a first notch along the indentation of the first insulating substrate, and a notch along the indentation in the roof, both first and second notches being positioned so that they overlay one another.
0. 30. The test strip of claim 29 wherein the roof has a solid transparent or translucent window, which is dimensioned and positioned so that the window overlays the entire width of the electrically conductive track that is closest to the indentation of the first insulating substrate and at least about ten percent of the width of the other electrically conductive track.
0. 31. A test strip comprising:
a first insulating substrate having first and second surfaces and a notch along an edge;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces and an opening, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the second insulating substrate configured to expose a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the opening being located along an edge of the second insulating substrate and exposing a different portion of the conductive tracks, aid overlaying the notch in the first insulating substrate;
a test reagent overlaying at least a portion of the conductive tracks exposed by the opening;
a roof having first and second surfaces and a notch along an edge, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so that 1) the second surface of the roof and the first surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate, and 2) the notch in the roof overlays the notch in the first insulating substrate; and
a vent hole communicating with the capillary fill chamber;
whereby the notch in the roof and the notch in the first insulating substrate will cause a liquid aqueous sample, when touched to the sample application port, to flow into the capillary chamber without significant hesitation.
0. 32. A test strip comprising:
a first insulating substrate having first and second surfaces;
at least two electrically conductive tracks affixed to the first surface of the first insulating substrate;
a second insulating substrate having first and second surfaces and an opening, the second surface being affixed to the conductive tracks and the first surface of the first insulating substrate, the second insulating substrate configured to expose a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the opening being located along an edge of the second insulating substrate and exposing a different portion of the conductive tracks;
a test reagent overlaying at least a portion of the conductive tracks exposed by the opening;
a roof having first and second surfaces and a solid transparent or translucent window, the second surface of the roof being affixed to the first surface of the second insulating substrate and positioned so that it overlays the opening of the second insulating substrate and so that the second surface of the roof and the first surface of the first insulating substrate form opposing walls of a capillary fill chamber with a sample application port at said edge of the second insulating substrate, and the transparent or translucent window being dimensioned and positioned so that the window extends from the sample application port, and overlays the entire width of one of the electrically conductive tracks and at least about ten percent of the width of the other electrically conductive track; and
a vent hole communicating with the capillary fill chamber.
0. 34. The test strip of claim 33 in which the opposed sides of the capillary channel are parallel and extend in a straight line from the sample application port, and orthogonal to the perimetric edge surface, to at least one of the electrodes.
0. 35. The test strip of claim 34 in which the opaque portions are spaced apart to reveal greater than about 75% of the width of the capillary channel.
0. 36. The test strip of claim 35 in which the opaque portions are aligned with the opposed sides of the capillary channel.
0. 37. The test strip of claim 33 in which said strip body includes a first substrate, a second substrate and a roof, the second substrate being positioned intermediate the first substrate and the roof and including an opening, the opening of the second substrate together with the first substrate and the roof defining the capillary channel.
0. 38. The test strip of claim 37 in which said test strip includes conductive tracks connected with said working and counter electrodes, the first substrate having first and second surfaces, the working and counter electrodes being affixed to the first surface of the first substrate, the second substrate having first and second surfaces and an opening, the second surface of the second substrate being affixed to the first surface of the first substrate, the second substrate configured to expose a portion of the conductive tracks for electrical connection to a meter capable of measuring an electrical property, the opening being located along a perimetric edge surface of the second substrate and exposing said electrodes, and a roof having first and second surfaces and including a solid, transparent or translucent, viewing material, the second surface of the roof being affixed to the first surface of the second substrate and positioned so that it overlays the opening of the second substrate and so that the second surface of the roof and the first surface of the first substrate form opposing walls of the capillary channel, the transparent or translucent viewing material extending from at least adjacent to the sample application port and overlying the entire width of one of the electrodes and at least about ten percent of the width of the other electrode.
0. 39. The test strip of claim 37 in which the second substrate defines the opposed sides of the capillary channel, the sides being parallel and extending in a straight line from the sample application port, and orthogonal to the perimetric edge surface, to at least one of the electrodes.
0. 40. The test strip of claim 39 in which the opaque portions are spaced apart to reveal greater than about 75% of the width of the capillary channel.
0. 41. The test strip of claim 40 in which the opaque portions are aligned with the opposed sides of the capillary channel.
0. 42. The test strip of claim 41 in which the opaque portions are defined by the roof.
0. 44. The test strip of claim 43 in which the opaque portions are sized and dimensioned such that the blood sample is required to fill up to the electrodes the portion of the capillary channel viewable through the viewing material and between the opaque portions in order to have a sufficient amount of blood sample to conduct a test.
0. 45. The test strip of claim 43 in which the opaque portions extend continuously in alignment with the opposed sides of the capillary channel from the perimetric edge surface to the electrodes.
0. 46. The test strip of claim 45 in which the opaque portions are sized and dimensioned such that the blood sample is required to fill up to the electrodes the portion of the capillary channel viewable through the viewing material and between the opaque portions in order to have a sufficient amount of blood sample to conduct a test.
0. 47. The test strip of claim 33 in which the viewing area includes only the capillary channel.
0. 48. The test strip of claim 43 in which the viewing area includes only the capillary channel.


wherein [Analyte] represents the concentration of the analyte in the sample (see FIG. 6), i7.5 is the current (in microamps) measured at 7.5 seconds after application of the potential difference applied between the electrodes, C is the slope of line 30 (FIG. 6), and d is the axis intercept (FIG. 6).

By making measurements with known concentrations of analyte, calibration curve 30 (FIG. 6) may be constructed. This calibration will be stored in the Read Only Memory (ROM) key of the meter and will be applicable to a particular lot of test strips. Lines 31 and 32 in FIG. 6 represent other hypothetical calibration curves for two other different lots of test strips. Calibration for these biosensor lots would generate slightly different values for C and d in the above algorithm.

In a preferred method for analysis of glucose from a sample of human whole blood, current measurements are made at 0.5 second intervals from 3 seconds to 9 seconds after the potential difference is applied between the electrodes. These current measurements are correlated to the concentration of glucose in the blood sample.

In this example of measuring glucose from a blood sample, current measurements are made at different times (from 3 seconds to 9 seconds after application of the potential difference), rather than at a single fixed time (as described above), and the resulting algorithm is more complex and may be represented by the following equation:
[Glucose]=C1i1+C2i2+C3i3+ . . . Cnin+d,
wherein i1 is the current measured at the first measurement time (3 seconds after application of the 300 millivolt potential difference), i2 is the current measured at the second measurement time (3.5 seconds after application of the 300 millivolt potential difference), i3 is the current measured at the third measurement time (4 seconds after application of the 300 millivolt potential difference), in is the current measured at the nth measurement time (in this example, at the 13th measurement time or 9 seconds after application of the 300 millivolt potential difference), C1, C2, C3, and Cn are coefficients derived from a muiltivariate regression analysis technique, such as Principle Components Analysis or Partial Least Squares, and d is the regression intercept (in glucose concentration units).

Alternatively, the concentration of glucose in the sample being measured may be determined by integrating the curve generated by plotting current, i, versus measurement time over some time interval (for example, from 3 seconds to 9 seconds after application of the 300 millivolt potential difference), thereby obtaining the total charge transferred during the measurement period. The total charge transferred is directly proportional to the concentration of glucose in the sample being measured.

Further, the glucose concentration measurement may be corrected for differences between environmental temperature at the time of actual measurement and the environmental temperature at the time calibration was performed. For example, if the calibration curve for glucose measurement was constructed at an environmental temperature of 23° C., the glucose measurement is corrected by using the following equation:
[Glucose]corrected=[Glucose]measured×(1−K(T−23° C.)),
wherein T is the environmental temperature (in ° C.) at the time of the sample measurement and K is a constant derived from the following regression equation:
Y=K(T−23),
wherein

Y = [ Glucose ] measured at 23 ° C . - [ Glucose ] measured at 7 ° C . [ Glucose ] measured at 7 ° C .
In order to calculate the value of K, each of a multiplicity of glucose concentrations is measured by the meter at various temperatures, T, and at 23° C. (the base case). Next, a linear regression of Y on T−23 is performed. The value of K is the slope of this regression.

Various features of the present invention may be incorporated into other electrochemical test strips, such as those disclosed in U.S. Pat. Nos. 5,120,420; 5,141,868; 5,437,999; 5,192,415; 5,264,103; and 5,575,895, the disclosures of which are hereby incorporated by reference.

Surridge, Nigel A., Crismore, William F., McMinn, Daniel R.

Patent Priority Assignee Title
11230727, Oct 05 2016 Roche Diabetes Care, Inc. Detection reagents and electrode arrangements for multi-analyte diagnostic test elements, as well as methods of using the same
Patent Priority Assignee Title
3838033,
4224125, Sep 28 1977 Matsushita Electric Industrial Co., Ltd. Enzyme electrode
4254083, Oct 25 1978 CLINICAL DIAGNOSTIC SYSTEMS INC Structural configuration for transport of a liquid drop through an ingress aperture
4323536, Feb 06 1980 CLINICAL DIAGNOSTIC SYSTEMS INC Multi-analyte test device
4413407, Oct 25 1978 CLINICAL DIAGNOSTIC SYSTEMS INC Method for forming an electrode-containing device with capillary transport between electrodes
4432366, Nov 27 1981 SENTRON V O F , OOSTEINDE 8, 9301 LJ, RODEN, THE NETHERLANDS, A CORP OF NETHERLANDS Reference electrode catheter
4473457, Mar 29 1982 CLINICAL DIAGNOSTIC SYSTEMS INC Liquid transport device providing diversion of capillary flow into a non-vented second zone
4543326, Nov 12 1981 Wako Pure Chemical Industries, Ltd. Stabilization of oxidase
4654197, Oct 18 1983 MIGRATA U K LIMITED Cuvette for sampling and analysis
4684445, Jul 05 1985 Fuji Photo Film Co., Ltd. Method and device of measuring ion activity
4758323, May 05 1983 GENETICS INTERNATIONAL, INC Assay systems using more than one enzyme
4810633, Jun 04 1984 MILES INC Enzymatic ethanol test
4820399, Aug 31 1984 Shimadzu Corporation Enzyme electrodes
4830959, Nov 11 1985 MEDISENSE, INC Electrochemical enzymic assay procedures
4894137, Sep 12 1986 OMRON HEALTHCARE CO , LTD Enzyme electrode
4897173, Jun 21 1985 Matsushita Electric Industrial Co., Ltd. Biosensor and method for making the same
4938860, Jun 28 1985 MILES INC Electrode for electrochemical sensors
4959305, Jun 18 1986 Miles Inc. Reversible immobilization of assay reagents in a multizone test device
4999582, Dec 15 1989 Roche Diabetes Care, Inc Biosensor electrode excitation circuit
4999632, Dec 15 1989 Roche Diabetes Care, Inc Analog to digital conversion with noise reduction
5006310, Nov 03 1989 Allergan, Inc Schirmer tear test
5120420, Mar 31 1988 MATSUSHITA ELECTRIC INDUSTRIAL CO , LTD Biosensor and a process for preparation thereof
5126034, Jul 21 1989 MEDISENSE, INC , CAMBRIDGE, MA A CORP OF MA Bioelectrochemical electrodes
5141868, Feb 07 1986 Inverness Medical Switzerland GmbH Device for use in chemical test procedures
5170799, Feb 20 1988 Showa Yakuhin Kako Co., Ltd. Test strip for measuring tear production
5192415, Mar 04 1991 MATSUSHITA ELECTRIC INSTRIAL CO , LTD Biosensor utilizing enzyme and a method for producing the same
5229299, Apr 21 1992 Hach Company Test devices and methods for determining halides in aqueous samples
5243516, Dec 15 1989 Roche Diabetes Care, Inc Biosensing instrument and method
5252293, Jan 17 1989 MOLECULAR DEVICES, INC Analytical slide with porous filter membrane
5264103, Oct 18 1991 Panasonic Corporation Biosensor and a method for measuring a concentration of a substrate in a sample
5288636, Dec 15 1989 Roche Diagnostics Corporation Enzyme electrode system
5304468, Aug 13 1986 LifeScan, Inc. Reagent test strip and apparatus for determination of blood glucose
5310525, Feb 08 1990 Whatman PLC Fluid detection device
5320732, Jul 20 1990 Matsushita Electric Industrial Co., Ltd. Biosensor and measuring apparatus using the same
5352351, Jun 08 1993 Roche Diabetes Care, Inc Biosensing meter with fail/safe procedures to prevent erroneous indications
5354447, Dec 12 1991 Kyoto Daiichi Kagaku Co., Ltd. Biosensor and method of quantitative analysis using the same
5366609, Jun 08 1993 Roche Diabetes Care, Inc Biosensing meter with pluggable memory key
5366902, Oct 30 1990 Hypoguard Limited Collection and display device
5385846, Jun 03 1993 Roche Diabetes Care, Inc Biosensor and method for hematocrit determination
5395504, Feb 04 1993 Asulab S.A. Electrochemical measuring system with multizone sensors
5405511, Jun 08 1993 Roche Diabetes Care, Inc Biosensing meter with ambient temperature estimation method and system
5407554, May 10 1993 Asulab S.A. Electrochemical sensor with multiple zones on a disc and its application to the quantitative analysis of glucose
5413690, Jul 23 1993 Roche Diabetes Care, Inc Potentiometric biosensor and the method of its use
5437999, Feb 22 1994 Roche Diabetes Care, Inc Electrochemical sensor
5438271, Jun 08 1993 Roche Diabetes Care, Inc Biosensing meter which detects proper electrode engagement and distinguishes sample and check strips
5502396, Sep 21 1993 Asulab S.A. Measuring device with connection for a removable sensor
5508171, Dec 15 1989 Roche Diabetes Care, Inc Assay method with enzyme electrode system
5547702, Jul 08 1994 Roche Diabetes Care, Inc Method for continuous manufacture of diagnostic test strips
5563042, Aug 13 1986 LifeScan, Inc. Whole blood glucose test strip
5575895, Jun 02 1994 PHC HOLDINGS CO , LTD ; PANASONIC HEALTHCARE HOLDINGS CO , LTD Biosensor and method for producing the same
5695949, Apr 07 1995 LXN CORP Combined assay for current glucose level and intermediate or long-term glycemic control
5728352, Nov 14 1994 PA Consulting Group Disposable electronic diagnostic instrument
5798031, May 12 1997 Bayer Corporation Electrochemical biosensor
5843691, May 15 1993 Lifescan, Inc Visually-readable reagent test strip
5985116, Dec 24 1996 PHC HOLDINGS CO , LTD ; PANASONIC HEALTHCARE HOLDINGS CO , LTD Biosensor
6027692, Apr 07 1995 LXN Corporation Apparatus for combined assay for current glucose level and intermediate or long-term glycemic control
6207000, Apr 08 1998 Roche Diagnostics GmbH Process for the production of analytical devices
6488827, Mar 31 2000 Cilag GmbH International; Lifescan IP Holdings, LLC Capillary flow control in a medical diagnostic device
6491803, May 18 2001 Apex Biotechnology Corporation Test strip and biosensor incorporating with nanometer metal particles
6531040, Aug 02 1999 Ascensia Diabetes Care Holdings AG Electrochemical-sensor design
CN1148016,
EP10456,
EP80304,
EP127958,
EP136362,
EP170375,
EP206218,
EP230472,
EP359831,
EP400918,
EP407800,
EP537761,
EP732406,
GB2154003,
GB2204408,
JP1114746,
JP1114747,
JP1134244,
JP1156658,
JP5164756,
JP60173457,
JP60173458,
JP60173459,
JP6190050,
JP63128252,
JP63139246,
JP63317757,
JP63317758,
JP6358149,
JP6423153,
WO8908713,
///////////////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
May 01 1998HO, JIAXIONG JASONBoehringer Mannheim CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0202830128 pdf
May 04 1998MCMINN, DANIEL R Boehringer Mannheim CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0202830128 pdf
May 04 1998BODENSTEINER, RICHARD J Boehringer Mannheim CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0202830128 pdf
May 04 1998CRISMORE, WILLIAM F Boehringer Mannheim CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0202830128 pdf
May 06 1998BURKE, DAVID W Boehringer Mannheim CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0202830128 pdf
May 08 1998DIEBOLD, ERIC R Boehringer Mannheim CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0202830128 pdf
May 08 1998DELK, R DALEBoehringer Mannheim CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0202830128 pdf
May 13 1998SURRIDGE, NIGEL A Boehringer Mannheim CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0202830128 pdf
May 14 1998EARL, ROBERT KITCHELBoehringer Mannheim CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0202830128 pdf
May 14 1998HEALD, BRIAN A Boehringer Mannheim CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0202830128 pdf
Dec 11 1998Boehringer Mannheim CorporationRoche Diagnostics CorporationMERGER SEE DOCUMENT FOR DETAILS 0202820499 pdf
Dec 11 1998ROCHE DIAGNOSTIC SYSTEMS, INC Roche Diagnostics CorporationMERGER SEE DOCUMENT FOR DETAILS 0202830547 pdf
Dec 31 1998ROCHE DIAGNOSTIC SYSTEMS, INC Roche Diagnostics CorporationMERGER SEE DOCUMENT FOR DETAILS 0202820499 pdf
Oct 24 2003Roche Diagnostics Operations, Inc.(assignment on the face of the patent)
Oct 24 2003Roche Operations Ltd.(assignment on the face of the patent)
Jan 01 2004Roche Diagnostics CorporationRoche Diagnostics Operations, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0152010368 pdf
Jun 11 2007Roche Diagnostics Operations, IncCorange International LimitedASSIGNOR HEREBY CONFIRMS THE ASSIGNMENT TO CORANGE INTERNATIONAL LIMITED OF AN UNDIVIDED ONE-HALF INTEREST IN EACH OF THE APPLICATIONS0194190381 pdf
Jul 15 2008Corange International LimitedROCHE OPERATIONS LTD CHANGE OF NAME SEE DOCUMENT FOR DETAILS 0226340371 pdf
Mar 02 2015Roche Diagnostics Operations, IncRoche Diabetes Care, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0360080670 pdf
Date Maintenance Fee Events


Date Maintenance Schedule
Jul 19 20144 years fee payment window open
Jan 19 20156 months grace period start (w surcharge)
Jul 19 2015patent expiry (for year 4)
Jul 19 20172 years to revive unintentionally abandoned end. (for year 4)
Jul 19 20188 years fee payment window open
Jan 19 20196 months grace period start (w surcharge)
Jul 19 2019patent expiry (for year 8)
Jul 19 20212 years to revive unintentionally abandoned end. (for year 8)
Jul 19 202212 years fee payment window open
Jan 19 20236 months grace period start (w surcharge)
Jul 19 2023patent expiry (for year 12)
Jul 19 20252 years to revive unintentionally abandoned end. (for year 12)